“Crude oil futures continue to see high price swings and are currently down 0.5%, as focus remains on developments in the middle-east conflict and the progress of ceasefire talks. Also in focus will be China’s prime loan rate decision on Tuesday and the weekly oil inventory dat...
Furthermore, the increasing product launches and approvals in the region are also contributing to the growth of the market. For instance, in June 2022, the United States Food and Drug Administration approved Zydus's Adapalene and Benzoyl Peroxide Topical Gel, which is indicated to decrease the ...
In July 2022, Zydus Lifesciences announced that it had received final approval to market Empagliflozin and Metformin Hydrochloride tablets in multiple strengths. Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diab...
Esperion Therapeutics, Daiichi Sankyo, Zydus Lifesciences, Sun Pharmaceutical Industries, Akum Drugs & Pharmaceuticals, Cadila Pharmaceuticals, Merck & Co., AstraZeneca, CJ Healthcare, Sanofi Segments Covered By Product Type, By Application, By Distribution Channel, And By Geography ...
In May 2022, Zydus Lifesciences launched its Bempedoic acid drug in India under the Bemdac brand for the treatment of uncontrolled levels of bad cholesterol. Hyperlipidemia Drugs Market Report - Table of Contents 1. INTRODUCTION 1.1 Study Assumptions and Market Definition ...
January 2023:The Indian Drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) fixed the retail price of 12 scheduled formulations under the Drugs (Prices Control) Order, 2013 (NLEM 2022). The retail price of one tablet of anti-diabetes combination drug Glimepiride, Voglibose & Met...
Oral anti-diabetic agents present the advantages of easier management and lower cost and become an attractive alternative with better acceptance, which enhances adherence to the treatment. In July 2022, Zydus Lifesciences announced that it had received final approval from the USFDA to market ...
February 2023: Zydus Lifesciences Limited received tentative approval from the USFDA for Invokamet tablets (canagliflozin and metformin hydrochloride combination). Canagliflozin and metformin combination products are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type...
The companies are focusing on developing targeted therapy for breast cancer and increasing their focus on adopting different strategies to withhold their position in the market. For instance, in May 2021, Zydus Cadila launched Trastuzumab Emtansine, an antibody-drug conjugate biosimilar, Ujvira, to tr...
The Gastroesophageal Reflux Disease Market is growing at a CAGR of 4.3% over the next 5 years. Pfizer, Inc., Johnson & Johnson, SRS Life Sciences, Takeda Pharmaceutical Co., Ltd. and Haleon Group of Companies are the major companies operating in this mar